WallStreetZenWallStreetZen

NASDAQ: VRDN
Viridian Therapeutics Inc Stock Ownership - Who owns Viridian Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Viridian Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jennifer TousignantChief Legal Officer2026-03-031,675$30.19
$50.57kSell
Thomas W. BeethamChief Operating Officer2026-03-033,138$29.32
$92.01kSell
Thomas W. BeethamChief Operating Officer2026-03-033,048$30.19
$92.02kSell
Stephen F. MahoneyPresident and CEO2026-03-037,408$30.19
$223.65kSell
Jennifer TousignantChief Legal Officer2026-03-031,724$29.32
$50.55kSell
Jennifer TousignantChief Legal Officer2026-03-031,724$29.32
$50.55kSell
Thomas W. BeethamChief Operating Officer2026-03-033,138$29.32
$92.01kSell
Seth HarmonChief Financial Officer2026-03-032,091$29.32
$61.31kSell
Seth HarmonChief Financial Officer2026-03-032,091$29.32
$61.31kSell
Seth HarmonChief Financial Officer2026-03-032,031$30.19
$61.32kSell

1 of 2

VRDN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VRDN insiders and whales buy or sell their stock.

VRDN Shareholders

What type of owners hold Viridian Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC14.07%14,384,456$426.50MInstitution
Blackrock Inc6.29%6,431,923$190.71MInstitution
Logos Global Master Fund LP5.87%6,000,000$177.90MInsider
Vanguard Group Inc5.49%5,612,144$166.40MInstitution
Fairmount Funds Management LLC4.34%4,440,851$131.67MInsider
Bellevue Group Ag4.26%4,358,527$129.23MInstitution
Fairmount Funds Management LLC3.83%3,914,458$116.06MInstitution
Vr Adviser LLC3.80%3,882,709$115.12MInstitution
State Street Corp3.39%3,466,560$102.78MInstitution
Price T Rowe Associates Inc3.37%3,439,414$101.98MInstitution

1 of 3

VRDN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VRDN77.60%22.40%Net BuyingNet Selling
CPRX84.21%15.79%Net SellingNet Selling
ALMS74.53%25.47%Net BuyingNet Buying
ARQT77.27%22.73%Net SellingNet Selling
IDYA92.65%7.35%Net BuyingNet Buying
View Top Biotech Stocks

Viridian Therapeutics Stock Ownership FAQ

Who owns Viridian Therapeutics?

Viridian Therapeutics (NASDAQ: VRDN) is owned by 105.50% institutional shareholders, 30.45% Viridian Therapeutics insiders, and 0.00% retail investors. Logos Global Master Fund LP is the largest individual Viridian Therapeutics shareholder, owning 6.00M shares representing 5.87% of the company. Logos Global Master Fund LP's Viridian Therapeutics shares are currently valued at $175.14M.

If you're new to stock investing, here's how to buy Viridian Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.